US0758871091
© PR Newswire
15.12.2025
BDX
LISTED
NYSE
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec
News Preview
FRANKLIN LAKES, N.J., Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of tw...
Themefolio
Profiler
Peergroup
© PR Newswire
04.12.2025
BDX
LISTED
NYSE
BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories
News Preview
FRANKLIN LAKES, N.J., Dec. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ChemoGLO™, a specialist in hazardous drug detection and decontamination, today announced a strategic collaboration to advance hazardous drug contamination testing in health care settings to improve the...
Themefolio
Profiler
Peergroup
© PR Newswire
03.12.2025
BDX
LISTED
NYSE
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
News Preview
Three- and Four-Laser BD FACSDiscover™ A8 Cell Analyzers Expand Accessibility of Spectral, Real-Time Imaging Cell AnalysisFRANKLIN LAKES, N.J., Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new configurations of cell analyze...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
24.11.2025
BDX
LISTED
NYSE
BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety
News Preview
FRANKLIN LAKES, N.J., Nov. 24, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Surgiphor™ Surgical Wound Irrigation System in Europe. The system is the first of its kind to receive Conformité Européenne (CE) approval and is now available in selec...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
17.11.2025
BDX
LISTED
NYSE
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors
News Preview
FRANKLIN LAKES, N.J., Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert "Robbie" Huffines and Jacqueline "Jacky" Wright to its board of directors, effective Dec. 1, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
17.11.2025
BDX
LISTED
NYSE
BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification
News Preview
RANKLIN LAKES, N.J., Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne (CE) Marked BD Onclarity™ HPV Assay for the BD COR™ System and the BD Viper™ LT System have been accepted for the World Hea...
Themefolio
Profiler
Peergroup
© PR Newswire
13.11.2025
BDX
LISTED
NYSE
Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH
News Preview
FRANKLIN LAKES, N.J., Nov. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Duncan Regional Hospital ("DRH Health") has become the first hospital in the United States to implement BD Alaris™ EMR (Electronic Medical Record) I...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
BDX
LISTED
NYSE
BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go
News Preview
FRANKLIN LAKES, N.J., Nov. 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, introduces the PureWick™ Portable Collection System, a discreet, first-of-its-kind, battery-powered personal urine management device designed for wheelchair users to hel...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
BDX
LISTED
NYSE
BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
News Preview
Q4 revenue of $5.9 billion increased 8.3% as reported, 7.0% FXN and 3.9% organic
Q4 GAAP and adjusted diluted EPS grew to $1.72 and $3.96, respectively
FY25 revenue of $21.8 billion increased 8.2% as reported, 7.7% adjusted FXN and 2.9% organic
FY25 GAAP EPS o...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
BDX
LISTED
NYSE
BD Board Increases Dividend for 54th Consecutive Year
News Preview
FRANKLIN LAKES, N.J., Nov. 6, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.05 per common share, an increase of 1.0% from the previous quarter. The dividend will be payable on December 31, 2025 to holders of record on December...
Themefolio
Profiler
Peergroup
© PR Newswire
04.11.2025
BDX
LISTED
NYSE
BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease
News Preview
FRANKLIN LAKES, N.J., Nov. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device Exemption (IDE) study, a prospective, multi-center study evalua...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
BDX
LISTED
NYSE
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System
News Preview
FRANKLIN LAKES, N.J., Nov. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européenne (CE) marking in the European Union for its Enteric Bacte...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
22.10.2025
BDX
LISTED
NYSE
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
News Preview
FRANKLIN LAKES, N.J., Oct. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV testing in markets outside the United States. This new innovation simplifies at-home sample collection for patient...
Themefolio
Profiler
Peergroup
© PR Newswire
20.10.2025
BDX
LISTED
NYSE
BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings
News Preview
FRANKLIN LAKES, N.J., Oct. 20, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global leader in medical technology, introduces the BD Incada™ Connected Care Platform, a new scalable, AI-enabled, cloud-based platform that unifies BD device data into one intelligent ecosystem for the first ti...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
BDX
LISTED
NYSE
BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region
News Preview
BROKEN BOW, Neb., Oct. 16, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, proudly commemorates 65 years of manufacturing excellence at its Broken Bow, Nebraska facility—a cornerstone of BD's extensive U.S. manufacturing network....
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
BDX
LISTED
NYSE
BD Announces CFO Transition Plan
News Preview
Provides Preliminary Revenue for Fourth Quarter and Full Year Fiscal 2025
FRANKLIN LAKES, N.J., Oct. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, an...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
BDX
LISTED
NYSE
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025
News Preview
FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, November 6, 2025 to discuss the Company's financial results for its fourth quarter...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
BDX
LISTED
NYSE
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
News Preview
FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
BDX
LISTED
NYSE
BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation
News Preview
FRANKLIN LAKES, N.J., Oct. 8, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a multi-year collaboratio...
Themefolio
Profiler
Peergroup
© PR Newswire
03.10.2025
BDX
LISTED
NYSE
BD Celebrates 55 Years of Manufacturing Excellence and Impact in Sumter, S.C.
News Preview
SUMTER, S.C., Oct. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today will commemorate 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout its history has been a core site within the Company's extensi...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
BDX
LISTED
NYSE
BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery
News Preview
FRANKLIN LAKES, N.J., Sept. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a pharmacy automation partnership with Henry Ford Health to develop the health system pharmacy of the future, with an initial focus on a robotic solution that will enable patients to pic...
Themefolio
Profiler
Peergroup
© PR Newswire
17.09.2025
BDX
LISTED
NYSE
BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics
News Preview
FRANKLIN LAKES, N.J., Sept. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ System, a flagship instrument for single-cell multiomics analysis, at Addenbrooke's Hospital of the University of Cambridge, United Kingdom. Together...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
BDX
LISTED
NYSE
BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative
News Preview
FRANKLIN LAKES, N.J., Sept. 2, 2025 /PRNewswire/ -- In recognition of Peripheral Artery Disease (PAD) Awareness Month, BD (Becton, Dickinson and Company) (NYSE: BDX) is shining a spotlight on a serious yet often overlooked circulatory disorder that restricts blood flow to the limbs and is a leading cause of preventable amputations....
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2025
BDX
LISTED
NYSE
BD to Present at Wells Fargo 2025 Healthcare Conference
News Preview
FRANKLIN LAKES, N.J., Aug. 14, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2025 Healthcare Conference on Wednesday, September 3, 2025 at 8:00 a.m. Eastern Time.
The live webcast of BD's presentation can be accessed from t...
Themefolio
Profiler
Peergroup
© PR Newswire
07.08.2025
BDX
LISTED
NYSE
BD Reports Third Quarter Fiscal 2025 Financial Results
News Preview
Revenue of $5.5 billion increased 10.4% as reported, 8.5% adjusted FXN and 3.0% organicGAAP and adjusted diluted EPS grew to $2.00 and $3.68, respectivelyGAAP and adjusted gross margin up 160 basis points and 50 basis points, respectively, driven by BD ExcellenceGAAP and adjusted operating income up 46.6% and 11.3%, respectivelyCompany raises ful...
Themefolio
Profiler
Peergroup
© PR Newswire
05.08.2025
BDX
LISTED
NYSE
BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories
News Preview
FRANKLIN LAKES, N.J., Aug. 5, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UCC) and Surgery business units are the first in the medical technology industry to achieve a diamond-level rating for all seven supply chain resilience...
Themefolio
Profiler
Peergroup
© PR Newswire
04.08.2025
BDX
LISTED
NYSE
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care
News Preview
FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, Neb. facility to increase the resiliency of the U.S...
Themefolio
Profiler
Peergroup
© PR Newswire
31.07.2025
BDX
LISTED
NYSE
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home
News Preview
New FDA Submission Includes Self-Collection Swab and High-Tech Laboratory Robotics that Report More High-Risk HPV Strains Than Any Other Test
FRANKLIN LAKES, N.J., July 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has submitted an application to the U.S. F...
Themefolio
Profiler
Peergroup
© PR Newswire
30.07.2025
BDX
LISTED
NYSE
BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test
News Preview
New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making
FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Veritor™ Syste...
Themefolio
Profiler
Peergroup
© PR Newswire
23.07.2025
BDX
LISTED
NYSE
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
News Preview
FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics. ...
Themefolio
Profiler
Peergroup
© PR Newswire
22.07.2025
BDX
LISTED
NYSE
BD Board Declares Dividend
News Preview
FRANKLIN LAKES, N.J., July 22, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on September 30, 2025 to holders of record on September 8, 2025. The indicated annual div...
Themefolio
Profiler
Peergroup
© PR Newswire
07.07.2025
BDX
LISTED
NYSE
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
News Preview
FRANKLIN LAKES, N.J., July 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective July 2, Bilal Muhsin has been named executive vice president and will become the president of BD's future Connected Care segment, as part of the company's previously announ...
Themefolio
Profiler
Peergroup
© PR Newswire
28.05.2025
BDX
LISTED
NYSE
BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
News Preview
FRANKLIN LAKES, N.J., May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data registry for the Rotarex™ Atherectomy System to measure real-world outcomes for patients with peripheral artery disease (PAD)....
Themefolio
Profiler
Peergroup
© PR Newswire
27.05.2025
BDX
LISTED
NYSE
BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference
News Preview
FRANKLIN LAKES, N.J., May 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 2:00 pm Eastern Time.
The live webcast of BD's presentation can be accessed f...
Themefolio
Profiler
Peergroup
© PR Newswire
21.05.2025
BDX
LISTED
NYSE
Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'
News Preview
FRANKLIN LAKES, N.J., May 21, 2025 /PRNewswire/ -- First-of-their-kind studies published in The Lancet Oncology1 and Cancer Medicine2 provide new data showing that cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant (AMR) infections compared to all other non-cancer pati...
Themefolio
Profiler
Peergroup
© PR Newswire
13.05.2025
BDX
LISTED
NYSE
BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
News Preview
New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma
FRANKLIN LAKES, N.J., May 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the global commercial launch of the world's first cell analyzer...
Themefolio
Profiler
Peergroup
© PR Newswire
12.05.2025
BDX
LISTED
NYSE
BD to Announce Financial Results for its Third Quarter of Fiscal 2025
News Preview
FRANKLIN LAKES, N.J., May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, August 7, 2025 to discuss the Company's financial results for its third quarter of fiscal year 2025, which ends on J...
Themefolio
Profiler
Peergroup
© PR Newswire
01.05.2025
BDX
LISTED
NYSE
BD Reports Second Quarter Fiscal 2025 Financial Results
News Preview
Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organicGAAP and adjusted diluted EPS of $1.07 and $3.35, respectivelyCompany updates full-year fiscal 2025 guidance and provides estimated tariff impactFRANKLIN LAKES, N.J., May 1, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading globa...
Themefolio
Profiler
Peergroup
© PR Newswire
30.04.2025
BDX
LISTED
NYSE
BD to Present at Bank of America Securities Health Care Conference
News Preview
FRANKLIN LAKES, N.J., April 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference on Tuesday, May 13, 2025 at 1:00 pm Eastern Time.
The live webcast of BD's presentation can be accessed fro...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
BDX
LISTED
NYSE
BD Board Declares Dividend
News Preview
FRANKLIN LAKES, N.J., April 29, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on June 30, 2025 to holders of record on June 9, 2025. The indicated annual dividend rat...
Themefolio
Profiler
Peergroup
© PR Newswire
23.04.2025
BDX
LISTED
NYSE
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
News Preview
Phasix™ ST Umbilical Hernia Patch Leverages Same Surgical Technique as Permanent Mesh Procedures
FRANKLIN LAKES, N.J., April 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the commercial lau...
Themefolio
Profiler
Peergroup
© PR Newswire
21.04.2025
BDX
LISTED
NYSE
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
News Preview
HemoSphere Alta™ Advanced Monitoring Platform with Predictive, Smart Algorithms Helps Clinicians Proactively Address Instability in Blood Flow and Pressure in Critical Situations
FRANKLIN LAKES, N.J., April 21, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has launched a new adva...
Themefolio
Profiler
Peergroup
© PR Newswire
03.04.2025
BDX
LISTED
NYSE
BD to Announce Financial Results for its Second Quarter of Fiscal 2025
News Preview
FRANKLIN LAKES, N.J., April 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, May 1, 2025 to discuss the Company's financial results for its second quarter of fiscal year 2025, which ended on M...
Themefolio
Profiler
Peergroup
© PR Newswire
31.03.2025
BDX
LISTED
NYSE
BD Named One of America's Most Innovative Companies by Fortune
News Preview
FRANKLIN LAKES, N.J., March 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall. The list recognizes organizations that excel in developing innovative products...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
BDX
LISTED
NYSE
BD Names Gregory J. Hayes to Board of Directors
News Preview
FRANKLIN LAKES, N.J., March 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J. Hayes to its board of directors, effective March 26, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
20.03.2025
BDX
LISTED
NYSE
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery
News Preview
FRANKLIN LAKES, N.J., March 20, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial intended to advance BD's efforts to achieve Premarket Approval (PMA) from the U.S. Food and Drug Adm...
Themefolio
Profiler
Peergroup
© PR Newswire
13.02.2025
BDX
LISTED
NYSE
BD to Present at Investor Healthcare Conferences
News Preview
FRANKLIN LAKES, N.J., Feb. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences:
Citi's 2025 Unplugged Medtech and Life Sciences Access DayFebruary 27, 20258:45 a.m. Eastern Time
Barclays 27th Annual Globa...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
BDX
LISTED
NYSE
BD Reports First Quarter Fiscal 2025 Financial Results
News Preview
Company Delivers Revenue, Margin and Earnings Ahead of its Expectations
Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organicGAAP and adjusted diluted EPS of $1.04 and $3.43 grew 8.3% and 28.0%, respectivelyBD completes $750 million share repurchase to date in FY25Company increases FY25 adjusted diluted EPS gu...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
BDX
LISTED
NYSE
BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value
News Preview
Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD 2025 strategy, will be well-positioned as a scaled, pure-play MedTech leader focused on attractive categories shaping the future of health careBiosciences...
Themefolio
Profiler
Peergroup
© PR Newswire
28.01.2025
BDX
LISTED
NYSE
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25
News Preview
FRANKLIN LAKES, N.J., Jan. 28, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on March 31, 2025 to holders of record on March 10, 2025. The indicated annual dividend r...
Themefolio
Profiler
Peergroup
© PR Newswire
23.01.2025
BDX
LISTED
NYSE
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
News Preview
FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm i...
Themefolio
Profiler
Peergroup
© PR Newswire
22.01.2025
BDX
LISTED
NYSE
Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care
News Preview
ROANOKE, Va. and FRANKLIN LAKES, N.J., Jan. 22, 2025 /PRNewswire/ -- Carilion Clinic, a not-for-profit health care organization serving more than 1 million people in Virginia, in partnership with BD, (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Carilion is the first health system i...
Themefolio
Profiler
Peergroup
© PR Newswire
16.01.2025
BDX
LISTED
NYSE
BD to Announce Financial Results for its First Quarter of Fiscal 2025
News Preview
FRANKLIN LAKES, N.J., Jan. 16, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, February 6, 2025 to discuss the Company's financial results for its first quarter of fiscal year 2025, which ended...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2025
BDX
LISTED
NYSE
New Survey Reveals Nearly 3 in 4 Canadian Women Are Delaying Their OB/GYN Exams, Increasing Risks for Cervical Cancer
News Preview
83% Want More Accessible and Less Invasive Testing Options
MISSISSAUGA, ON, Jan. 15, 2025 /CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the results of a new survey revealing that 74% of women in Canada have delayed a gynecology visit, with 83% wanting more accessible and less inva...
Themefolio
Profiler
Peergroup
© PR Newswire
15.01.2025
BDX
LISTED
NYSE
BD Boosts U.S. Manufacturing of Critical Medical Devices
News Preview
FRANKLIN LAKES, N.J., Jan. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional investments in its U.S. manufacturing network to add capacity for critical medical devices, including syringes, needles and IV catheters, to meet the ongoing needs of the natio...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2025
BDX
LISTED
NYSE
New Survey Finds Women Are Skipping Their OB/GYN Exams, Increasing Risks for Cervical Cancer
News Preview
Women Are Seeking More Convenience and Less Discomfort in Testing Options
FRANKLIN LAKES, N.J., Jan. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey, revealing that 72% of women in the United States have delayed having a gynecology vi...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2025
BDX
LISTED
NYSE
BD To Host Virtual 2025 Annual Meeting of Shareholders
News Preview
FRANKLIN LAKES, N.J., Jan. 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2025 Annual Meeting of Shareholders (the "Annual Meeting") on Tuesday, January 28, 2025, at 1:00 p.m. (ET).
As described in the proxy materials for the Annua...
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2024
BDX
LISTED
NYSE
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
News Preview
FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, today announced an expansion of fingertip blood collection and testing technologies for use by U.S. health system...
Themefolio
Profiler
Peergroup
© PR Newswire
16.12.2024
BDX
LISTED
NYSE
BD Resolves Previously Disclosed SEC Investigation
News Preview
FRANKLIN LAKES, N.J., Dec. 16, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement:
BD has reached an agreement with the U.S. Securi...
Themefolio
Profiler
Peergroup
© PR Newswire
20.11.2024
BDX
LISTED
NYSE
First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities
News Preview
BROWNSVILLE, Texas, Nov. 20, 2024 /PRNewswire/ -- A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in underserved communities has officially launched in Texas. HPV is the cause of virtually all cervical cancers....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
